Answers are grounded in this paper and cite their sources.
We describe the development of cell-permeable beta-secretase inhibitors that demonstratively inhibit the production of the secreted amino terminal fragment of an artificial amyloid precursor protein in cell culture. In addition to potent inhibition in a cell-based assay (IC50 < 100 nM), these inhibitors display impressive selectivity against other biologically relevant aspartyl proteases.
No takes yet. Share an insight, caveat, or question.
Stachel et al. (2004) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: